There is so much stem cell hype out there that sometimes it seems like almost daily up comes a headline that is so full of hype that it could be harmful, but a new piece from The Telegraph really takes the cake. It is entitled, “Hope of cure for arthritis, MS and diabetes as Stanford …
Huge stem cell hype from Telegraph on new Stanford paper Read More »
Stem cell studies continue to make big news with a mixed bag of trends, and some good stem cell news and others not so much. Mesoblast ($MESO) had its stock suspended for quite so time recently in anticipation of a big announcement. When that news came today it was discouraging in the form of its partner …
Stem cell news bites: Mesoblast, BioTime, MS, FDA Warning, & More Read More »
The FDA has sent a Warning Letter to the Irvine Stem Cell Treatment Center. The leader of Irvine Stem Cell Treatment Center is Dr. Thomas Gionis and the letter was addressed to him. Interestingly, this letter, dated December 30, 2015, contains redactions. At one time this clinic was part of the larger Cell Surgical Network (CSN) …
FDA Warning Letter to Irvine Stem Cell Treatment Center Clinics Across US Read More »
For years I’ve been writing about fat stem cell clinics that sell non-FDA approved stem cell “treatments” to vulnerable patients right here in America. These clinics have been sprouting up like mushrooms across the US and their numbers may be above 200 today overall. As a result perhaps it was inevitable that one would arrive in …
My new ‘neighbor’ in Sacramento: a fat stem cell clinic Read More »
One of the many interesting ways in which “stem cells” are named in different languages around the world is “mother cells”. For example, in Spanish, you can learn more about these “mother cells” here in ¿Qué son las células madre? On Mother’s Day it is worth thinking about where the stem cell field stands at this …
Stem cells on Mother’s Day, clinical trials, and more Read More »
Who is Doug Broeska and what is Regenetek a Canadian stem cell company doing that is drawing attention of authorities? The Winnipeg Free Press is reporting that Regenetek faces serious charges related to for-profit stem cell therapies. (Update: a followup story in the Free Press has been published). A very thorough article in the newspaper …
Stem cell clinic & Doug Broeska face stem cell fraud allegations Read More »
StemCells Inc. is a top biotech company developing stem cell-based therapies. They have a deep pipeline that includes already ongoing trials for a variety of diseases. I invited company leadership to do an interview and they graciously accepted. Below is the interview with CFO Greg Schiffman (picture at left from LinkedIn) including what I thought …
Interview with StemCells Inc. leadership on hot topics Read More »
I’ve really enjoyed day 2 of ISSCR 2014. So far this day has already packed in a slew of great talks both in the lecture halls and outside one-on-one with old friends and new ones. How great is that? I’ll focus on just a few highlights to keep it concise. Dubious stem cell clinics and …
ISSCR 2014 Day 2: Navigating Balanced Stem Cell Path to Clinic Read More »
I did a brief email Q&A interview with Dr. Bob Lanza of Advanced Cell Technology (ACT) on their new hES MSCs pre-clinical data for Multiple Sclerosis. I discussed the paper itself in a concise review yesterday here. Thanks to Dr. Lanza for doing the interview. 1. Were you surprised at the fact that the therapeutic …
Interview with Bob Lanza on new ACT MSCs for MS paper Read More »
There is more good news from leading stem cell biotech Advanced Cell Technology (ACT) on preclinical rodent studies using stem cells to treat mice with an MS-like condition. They published a new paper in the journal Stem Cell Reports entitled “Human ESC-Derived MSCs Outperform Bone Marrow MSCs in the Treatment of an EAE Model of …
Advanced Cell Technology (ACT) Revs Up Pre-Clinical Studies for MS Read More »